Choosing the appropriate pharmacotherapy for multidrug-resistant Gram positive infections

被引:10
作者
Fiore, Marco [1 ]
Taccone, Fabio Silvio [2 ]
Leone, Sebastiano [3 ]
机构
[1] Univ Campania Luigi Vanvitelli, Dept Anaesthesiol Surg & Emergency Sci, Naples, Italy
[2] ULB, Hop Erasme, Dept Intens Care, Brussels, Belgium
[3] San Giuseppe Moscati Hosp, Div Infect Dis, Avellino, Italy
关键词
Multidrug resistance; MRSA; VRE; treatment options; BLOOD-STREAM INFECTIONS; STAPHYLOCOCCUS-AUREUS; ENTEROCOCCUS-FAECIUM; DAPTOMYCIN; VANCOMYCIN; SAFETY;
D O I
10.1080/14656566.2018.1512584
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1517 / 1521
页数:5
相关论文
共 50 条
[31]   Parenteral colistin for the treatment of severe infections by multidrug-resistant Gram-negative bacteria [J].
C Grion ;
MT Tanita ;
CM Dantas de Maio Carrilho ;
JP Garcia ;
J Festti ;
LTQ Cardoso ;
F Chiquetti ;
MM Kanehissa ;
CC Branco Lopes ;
D Blum ;
V Anami ;
AR Ruiz ;
PA Rossatto .
Critical Care, 17 (Suppl 3)
[32]   Landscape of Multidrug-Resistant Gram-Negative Infections in Egypt: Survey and Literature Review [J].
El-Kholy, Amani ;
El-Mahallawy, Hadir A. ;
Elsharnouby, Noha ;
Aziz, Mohamed Abdel ;
Helmy, Ahmed Mohamed ;
Kotb, Ramy .
INFECTION AND DRUG RESISTANCE, 2021, 14 :1905-1920
[33]   Novel approaches for the treatment of infections due to multidrug-resistant bacterial pathogens [J].
Imran, Mohmmad ;
Ahmad, Mohammad Naiyaz ;
Dasgupta, Arunava ;
Rana, Preeti ;
Srinivas, Nanduri ;
Chopra, Sidharth .
FUTURE MEDICINAL CHEMISTRY, 2022, 14 (15) :1133-1148
[34]   SD-8, a novel therapeutic agent active against multidrug-resistant Gram positive cocci [J].
Mishra, Biswajit ;
Srivastava, Vipul Kumar ;
Chaudhry, Rama ;
Somvanshi, Rishi Kumar ;
Singh, Abhay Kumar ;
Gill, Kamaldeep ;
Somvanshi, Ramesh ;
Patro, Ishan Kumar ;
Dey, Sharmistha .
AMINO ACIDS, 2010, 39 (05) :1493-1505
[35]   Prevalence of multidrug-resistant bacteria associated with polymicrobial infections [J].
Kim, Hak-Jae ;
Na, Sae Won ;
Alodaini, Hissah Abdulrahman ;
Al-Dosary, Munirah Abdullah ;
Nandhakumari, P. ;
Dyona, L. .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (12) :1864-1869
[36]   AMXT-1501 targets membrane phospholipids against Gram-positive and -negative multidrug-resistant bacteria [J].
Zheng, Jinxin ;
Liu, Xiaoju ;
Xiong, Yanpeng ;
Meng, Qingyin ;
Li, Peiyu ;
Zhang, Fan ;
Liu, Xiaoming ;
Lin, Zhiwei ;
Deng, Qiwen ;
Wen, Zewen ;
Yu, Zhijian .
EMERGING MICROBES & INFECTIONS, 2024, 13 (01)
[37]   Patient Experiences and Perceptions with Infections Due to Multidrug-Resistant Organisms: A Systematic Review [J].
AlRawashdeh, Mousa M. ;
Ishak, Angela ;
Al-Bunnia, Ahmed ;
Agouridis, Aris P. ;
Lytras, Theodore ;
Spernovasilis, Nikolaos ;
Tsioutis, Constantinos .
PATHOGENS, 2024, 13 (09)
[38]   Repurposing Thiram and Disulfiram as Antibacterial Agents for Multidrug-Resistant Staphylococcus aureus Infections [J].
Long, Timothy E. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (09)
[39]   Colistin efficacy in the treatment of multidrug-resistant and extremely drug-resistant gram-negative bacterial infections [J].
Cetin, Cigdem Banu ;
Ozer Turk, Deniz ;
Senol, Sebnem ;
Dinc Horasan, Gonul ;
Tunger, Ozlem .
TURKISH JOURNAL OF MEDICAL SCIENCES, 2016, 46 (05) :1379-1384
[40]   Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria [J].
Giacobbe, Daniele Roberto ;
Mikulska, Malgorzata ;
Viscoli, Claudio .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (12) :1219-1236